Patents by Inventor Erica Carrier

Erica Carrier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods of treating cardiac fibrosis with ifetroban
    Patent number: 10016399
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: July 10, 2018
    Assignees: Cumberland Pharmaceuticals Inc., Vanderbilt University
    Inventors: Leo Pavliv, Bryan Voss, James West, Erica Carrier
  • Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists
    Publication number: 20170340614
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Application
    Filed: May 11, 2017
    Publication date: November 30, 2017
    Applicants: Cumberland Pharmaceuticals, Inc., Vanderbilt University
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • IFETROBAN TREATMENT FOR SYSTEMIC SCLEROSIS
    Publication number: 20170312255
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 27, 2017
    Publication date: November 2, 2017
    Applicants: Cumberland Pharmaceuticals, Inc., Vanderbilt University
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
    Publication number: 20170258771
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 14, 2017
    Inventors: Leo Pavliv, Bryan Voss, James West, Erica Carrier
  • Compositions and methods of treating cardiac fibrosis with ifetroban
    Patent number: 9693998
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: July 4, 2017
    Assignees: Cumberland Pharmaceuticals, Inc., Vanderbilt University
    Inventors: Leo Pavliv, Bryan Voss, James West, Erica Carrier
  • Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
    Publication number: 20150328190
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 18, 2015
    Publication date: November 19, 2015
    Inventors: Leo PAVLIV, Bryan Voss, James West, Erica Carrier